Exact Sciences Corporation
EXAS
$103.75
-$0.19-0.18%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 3.25% | 4.89% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.25% | 4.89% | |||
| Cost of Revenue | -1.59% | 7.31% | |||
| Gross Profit | 5.46% | 3.82% | |||
| SG&A Expenses | 8.15% | 3.76% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.70% | 5.37% | |||
| Operating Income | -7,985.62% | -136.50% | |||
| Income Before Tax | -379.15% | -31,052.63% | |||
| Income Tax Expenses | -52.53% | 62.85% | |||
| Earnings from Continuing Operations | -338.68% | -1,553.50% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -338.68% | -1,553.50% | |||
| EBIT | -7,985.62% | -136.50% | |||
| EBITDA | -145.83% | -5.46% | |||
| EPS Basic | -337.68% | -1,542.86% | |||
| Normalized Basic EPS | -1,335.27% | 39.13% | |||
| EPS Diluted | -337.68% | -1,542.86% | |||
| Normalized Diluted EPS | -1,335.27% | 39.13% | |||
| Average Basic Shares Outstanding | 0.25% | 0.19% | |||
| Average Diluted Shares Outstanding | 0.25% | 0.19% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||